Name: AEON Balance Sheet - Aeon Biopharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

AEON - Aeon Biopharma, Inc.

USD | NYSE | Healthcare

AEON Balance Sheet - Aeon Biopharma Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Cash And Short Term Investments
Cash And Equivalents	3.0	0.0	31.2	9.7	0.5	-
Restricted Cash	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-
Cash And Short Term Investments	3.0	0.0	31.2	9.7	0.5	-
Receivables
Accounts Receivable	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-
Prepaid Expenses	0.4	1.6	-	0.1	0.3	-
Other Current Assets
Non-Current Assets
Property, Plant & Equipment Gross	0.5	0.5	-	0.5	-	-
Accumulated Depreciation	0.3	0.3	-	0.1	-	-
Current Liabilities
Accounts Payable	0.9	5.9	-	7.8	-	-
Short Term Debt	-	-	-	-	-	-
Deferred Revenue Current
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.9	1.1	-	0.2	-	-
Common Equity
Common Stock	0.0	0.0	-	0.0	-	-
Additional Paid In Capital	415.8	403.0	-	187.3	0.0	0.0
Retained Earnings
Supplementary Data
Total Debt	-	-	-	-	-	-
Net debt	-	-	-	-	-	-
Working Capital

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20
Cash And Short Term Investments
Cash And Equivalents	6.2	3.0	5.9	8.4	10.4	0.0	0.5	3.4	1.6	31.2	16.2	-	-	9.7	0.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Liabilities
Accounts Payable	1.5	0.9	2.5	3.9	2.4	5.9	4.6	3.0	6.5	-	4.0	-	-	7.8	-	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.3	0.3	0.2	0.2	0.2	0.1	0.1	0.1	0.2	-	0.3	-	-	0.3	-	-
Accrued Expenses	1.8	2.9	1.5	0.5	0.4	1.1	1.6	1.2	1.3	-	1.0	-	-	1.1	-	-	-	-
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	6.7	6.9	8.2	9.1	8.6	14.1	10.7	10.4	16.0	-	14.2	9.5	-	82.6	1.3	1.0

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.8	0.9	1.0	1.0	1.1	1.1	1.2	1.3	-	-	0.1	-	-	0.2	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	25.4	60.6	28.6	27.5	25.1	31.7	36.1	33.7	201.4	-	146.0	12.1	-	143.2	12.0	12.8

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	-	-	0.0	-	-	-	-	-	-	-	-
Additional Paid In Capital	465.9	415.8	413.8	413.3	411.2	403.0	401.6	399.6	393.2	-	379.7	0.0	-	187.3	0.0	0.0	-
Retained Earnings	(482.6)	(470.8)	(433.7)	(429.1)	(422.5)	(431.6)	(433.7)	(427.5)	(591.6)	-	(447.4)	(11.5)	-	(474.8)	(11.6)	(12.4)	-
Accumulated Other Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	17.1	-	-	-	-
Total Stockholders Equity	(16.8)	(55.0)	(19.9)	(15.9)	(11.3)	(28.6)	(32.1)	(27.9)	(198.4)	(310.8)	(128.4)	(11.5)	(270.4)	(287.5)	(11.6)	(12.4)
Total Equity	(16.8)	(55.0)	(19.9)	(15.9)	(11.3)	(28.6)	(32.1)	(27.9)	(198.4)	(310.8)	(128.4)	(283.9)	(270.4)	(270.4)	(237.6)	(228.2)	(223.8)	(223.8)

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	(0.0)	(3.5)	(0.8)	1.1	3.7	(12.6)	(8.4)	(6.4)	(13.5)	-	2.7	(8.9)	-	(72.7)	(1.2)	(0.7)	-	0.0
Book Value	(16.8)	(55.0)	(19.9)	(15.9)	(11.3)	(28.6)	(32.1)	(27.9)	(198.4)	(310.8)	(128.4)	(11.5)	(270.4)	(287.5)	(11.6)	(12.4)	(223.8)	(16.9)
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-